Disease · MONDO_0700081
Comparisons in its trials20
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 20
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Aerosolized Calfactant vs Usual Care: Air Leak | 14 of 241 | 11 of 236 | 477 | NCT03058666 | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: deaths from any cause | 0 of 241 | 1 of 236 | 477 | NCT03058666 | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: Intubation and Instillation of Liquid Surfactant | 69 of 241 | 120 of 236 | 477 | NCT03058666 | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: Respiratory Support Requirements | 65 of 241 | 124 of 236 | 477 | NCT03058666 | Trial comparisons |
| Aerosolized Calfactant vs Usual Care: serious adverse events | 13 of 241 | 14 of 236 | 477 | NCT03058666 | Trial comparisons |
| CHF5633 vs Poractant Alfa: deaths from any cause | 4 of 59 | 7 of 58 | 117 | NCT02452476 | Trial comparisons |
| CHF5633 vs Poractant Alfa: serious adverse events | 20 of 59 | 20 of 58 | 117 | NCT02452476 | Trial comparisons |
| CHF5633 vs Poractant Alfa: Number of Patients With Normal Breathing (Room Air) Within 24 Hours | 38 of 56 | 43 of 57 | 113 | NCT02452476 | Trial comparisons |
| Curosurf LISA vs Curosurf Endotracheal Tube: Efficacy: Neonates Needing Additional Surfactant Doses | 6 of 19 | 3 of 12 | 31 | NCT02772081 | Trial comparisons |
| Curosurf LISA vs Curosurf Endotracheal Tube: deaths from any cause | 1 of 19 | 1 of 12 | 31 | NCT02772081 | Trial comparisons |
| Curosurf LISA vs Curosurf Endotracheal Tube: Safety: Study Treatment Administration: Number of Participants for Whom the First Attempt Failed to Insert the Catheter/Endotracheal Tube | 5 of 19 | 5 of 12 | 31 | NCT02772081 | Trial comparisons |
| Curosurf LISA vs Curosurf Endotracheal Tube: serious adverse events | 1 of 19 | 2 of 12 | 31 | NCT02772081 | Trial comparisons |
| Calfactant vs Poractant Alfa: deaths from any cause | 0 of 15 | 0 of 15 | 30 | NCT02834624 | Trial comparisons |
| Calfactant vs Poractant Alfa: serious adverse events | 0 of 15 | 0 of 15 | 30 | NCT02834624 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: Number of Participants With Respiratory Failure or Death | 6 of 11 | 0 of 1 | 12 | NCT04264156 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: Number of Participants With Common Complications of Prematurity | 9 of 11 | 1 of 1 | 12 | NCT04264156 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: Mortality | 0 of 11 | 0 of 1 | 12 | NCT04264156 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: Number With BPD | 0 of 11 | 0 of 1 | 12 | NCT04264156 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: deaths from any cause | 0 of 11 | 0 of 1 | 12 | NCT04264156 | Trial comparisons |
| Lucinactant (160 mg/kg) + nCPAP vs nCPAP Only: serious adverse events | 2 of 11 | 0 of 1 | 12 | NCT04264156 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0700081/comparisons